Top tips: buying from an insolvent company
Dentons’ restructuring, insolvency and bankruptcy group considers the legal, commercial and practical issues when buying from an insolvent company.
Often it is in the interests of both buyer and seller to negotiate and complete a deal as soon as possible to preserve value in the business before goodwill is tainted with any stigma of insolvency or key employees, suppliers or customers leave the business.
Buying the business leaves most liabilities with the old corporate shell. You can buy the shares if you are interested in tax losses but you would need to do a lot of due diligence to find out if tax losses are available and often there isn’t time. You can sometimes hive down assets into an SPV and buy the shares in that. Share sales do depend on the person in control of the target being in control of the parent as well to approve any share sale…
Click on the link below to read the rest of the Dentons briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from Dentons
News from The Lawyer
Briefings from Dentons
In January and February the CMA is conducting site visits, visiting a number of parties to the investigation to find out how they carry on their business and differentiate their offers.
Hedge fund manager Kyle Bass plans to take on some of the world’s largest drug producers by challenging the patents that protect their top products.
Analysis from The Lawyer
Life in Canada is getting harder for firms as commodities prices fall and work volumes slow
Which firms are cutting it in this era of slimline rosters, and who are the GC new brooms making clean sweeps? The Lawyer can reveal all